It’s up to researchers and lawmakers alike to find the right balance between regulation and freedom. Scientific experts should work to create a set of standardized, agreed-upon guidelines that specify the safest methods of CRISPR delivery, prioritize disease-causing genes for research, and set quality-control standards to evaluate gene-editing interventions. And government officials—especially in the United States—need to take a more active role than they have so far, pursuing robust legislation while also soliciting the opinions of their constituents and encouraging public participation,
